Bioventus received FDA clearance for Durolane, a single injection hyaluronic acid device used for joint lubrication in the treatment of knee osteoarthritis pain.
Spinal Tech
Smith & Nephew signed a three year partnership with Imperial College London to develop enhanced surgical techniques relating to ligament function, biomechanics and knee soft tissue injuries.
Mainstay Medical announced its half year financial report and an update on its ReActiv8 clinical trial.
Mazor Robotics' shares reached a new 52-week high of $49.64 on Sept. 1.
ApiFix entered into an exclusive distribution agreement with Joint Solutions Alliance Corp. in Canada, according to MarketsInsider.
Advertisement
Jason Hannon will take the helm of Mainstay Medical Oct. 9, according to MarketsInsider.
Medtronic launched new long-term clinical studies to collect prospective data on posterolateral fusion and transforaminal lumbar interbody fusion procedures using Infuse Bone Graft.
Here are six key notes on orthopedic and spine device companies from the past week.
Stryker finalized its Novadaq Technologies acquisition for $701 million. They announced plans to purchased Novadaq Technologies in June.
The global surgical navigation systems market is predicted to grow at a 6.5% CAGR and reach $906.8 million by 2021, according to medGadget.